TIBER CREEK GROUP for ASTRAZENECA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376 - Build Back Better Act, Subtitle J; Inflation Reduction Act of 2022 (PL 117-169), Subtitle B - Prescription Drug Pricing Reform; Issues relating to Part D pricing reform; Issues relating to Medicare Part D and Part B Pricing Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| COREY MALMGREN | — |
| TIMOTHY ROBINSON New | Chief Counsel, House Energy & Commerce Committee (2015-2022); LD & Senior Policy Counsel, Rep. Rush (2012-2015); House Subcommittee on Commerce, Trade, & Consumer Protection (2009-2012) |
Health Issues HCR
S. 4446 - Modernizing Accelerated Approval Pathway Act of 2022; H.R. 6584 - DEPICT Act; S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; H.R. 7667 - Food and Drug Amendments of 2022; H.R. 6833 - The Continuing Resolution and Ukraine Supplemental Appropriations Act 2023, Division F - FDA User Fee Reauthorization Act of 2022; H.R. 7559 - the Prescription Information Modernization Act; Package Inserts/eLabeling Issues (H.R. 7559, Prescription Information Modernization Act of 2022).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| COREY MALMGREN | — |
| TIMOTHY ROBINSON New | Chief Counsel, House Energy & Commerce Committee (2015-2022); LD & Senior Policy Counsel, Rep. Rush (2012-2015); House Subcommittee on Commerce, Trade, & Consumer Protection (2009-2012) |
Trade (domestic/foreign) TRD
Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.